Literature DB >> 15929193

Expression of gamma-aminobutyric acid A receptor subunits alpha1, beta1, gamma2 mRNA in rats with hepatic encephalopathy.

Xiao-Qing Li1, Lei Dong, Zhong-Hua Liu, Jin-Yan Luo.   

Abstract

AIM: To investigate the mRNA expression of gamma-aminobutyric acid A (GABA(A)) receptor subunits alpha(1), beta(1), gamma(2) in different parts of the brain of rats with hepatic encephalopathy.
METHODS: Twelve adult male Sprague-Dawley rats were randomly divided into two groups: (1) hepatic encephalopathy model group (n = 6), which was induced by intraperitoneal injection of thioacetamide (TAA, 350 mg/kg) for three consecutive days; (2) control group (n = 6), in which the rats were treated with same dose of normal saline solution. After the freeze slice of cerebrum was made, in situ hybridization was used to detect the mRNA of GABAA receptor subunits alpha(1), beta(1), and gamma(2) in rat cerebral cortex, basal nuclei, substantia nigra and hippocampi. Image data were collected and analyzed quantitatively by QWin550CW model image signal gather and analysis system.
RESULTS: In rats with hepatic encephalopathy, mRNA expression levels of GABA(A) receptor subunits alpha(1), beta(1) increased significantly in basal nuclei, substantia nigra pars compacta, substantia nigra pars reticularis and hippocampi (144.7+/-15.67/184.14+/-4.41, 60.61+/-33.66/113.07+/-32.44, 87.71+/- 21.25/128.40+/-18.85, 122.34+/-5.56/161.60+/-4.56, 123.29+/-5.21/140.65+/-4.15, 123.40+/-4.42/140.09+/-4.52, 124.76+/-4.18/140.09+/-4.12, 141.62+/-15.09/182.80 +/-5.20, 69.13+/-30.74/134.21+/-43.76, 87.87+/-25.16/151.01+/-19.49, 122.14+/-6.30 /162.33+/-3.92, 122.81+/-5.09/137.19+/-7.12, 123.00+/-4.63/138.11+/-5.92, 125.75 +/-2.43/138.81+/-6.10, P<0.01), but did not change in the cerebral cortex compared to the control group. Similar changes were found in the mRNA expression levels of GABA(A) receptor subunit gamma(2), which increased significantly in basal nuclei, substantia nigra pars compacta, substantia nigra pars reticularis (136.81+/-26.41/167.97+/-16.23, 51.00+/-36.14/113.18+/-36.52, 86.35+/-20.30/ 126.90+/-19.74, P<0.01), CA1 of hippocampal (162.15+/-9.05/178.62+/-6.45, P<0.05), and no changes were found in the cerebral cortex and CA2, CA3, CA4 of hippocampi.
CONCLUSION: In rats with hepatic encephalopathy, mRNA expression levels of GABA(A) receptor subunits alpha(1), beta(1), gamma(2) increase significantly in basal nuclei, substantia nigra and hippocampi, suggesting that the changes of mRNA expression levels in GABA(A) receptor subunits may contribute to the pathogenesis of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929193      PMCID: PMC4316074          DOI: 10.3748/wjg.v11.i21.3319

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  Structure and function of the basal ganglia - a non-clinical view.

Authors:  K E Webster
Journal:  Proc R Soc Med       Date:  1975-04

2.  Establishment of an animal model of hepatic encephalopathy.

Authors:  C J Chu; F Y Lee; S S Wang; F Y Chang; H C Lin; S L Wu; C C Chan; Y T Tsai; S D Lee
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2000-04

3.  Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.

Authors:  P Ferenci; G Grimm
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

4.  Compartmental distribution of endogenous amino acids in the substantia nigra of the rat.

Authors:  M Farrant; R A Webster
Journal:  Brain Res       Date:  1989-02-20       Impact factor: 3.252

Review 5.  Potential neural mechanisms in the pathogenesis of hepatic encephalopathy.

Authors:  D F Schafer; E A Jones
Journal:  Prog Liver Dis       Date:  1982

Review 6.  Benzodiazepines on trial: a research strategy for their rehabilitation.

Authors:  E Costa; A Guidotti
Journal:  Trends Pharmacol Sci       Date:  1996-05       Impact factor: 14.819

Review 7.  Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy.

Authors:  E Anthony Jones
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

8.  Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.

Authors:  D F Schafer; E A Jones
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

9.  [Changes in gamma-amino-butyric acid and N-methyl-D-aspartic acid receptor-gated currents from freshly isolated hippocampal CA1 pyramidal neurons of hepatic encephalopathy rats].

Authors:  Z Zhang; C Wu; P Zhou
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1997-06

10.  Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy.

Authors:  Samir Ahboucha; Paul Desjardins; Nicolas Chatauret; Gilles Pomier-Layrargues; Roger F Butterworth
Journal:  Neurochem Int       Date:  2003-11       Impact factor: 3.921

View more
  5 in total

Review 1.  Effects of hyperammonemia on brain energy metabolism: controversial findings in vivo and in vitro.

Authors:  Arne Schousboe; Helle S Waagepetersen; Renata Leke; Lasse K Bak
Journal:  Metab Brain Dis       Date:  2014-03-01       Impact factor: 3.584

2.  Expression of Glutamate Decarboxylase (GAD) mRNA in the brain of bile duct ligated rats serving as a model of hepatic encephalopathy.

Authors:  Renata Leke; Themis R Silveira; Thayssa D C Escobar; Arne Schousboe
Journal:  Neurochem Res       Date:  2013-08-01       Impact factor: 3.996

3.  Fragrant dioxane derivatives identify beta1-subunit-containing GABAA receptors.

Authors:  Olga A Sergeeva; Olaf Kletke; Andrea Kragler; Anja Poppek; Wiebke Fleischer; Stephan R Schubring; Boris Görg; Helmut L Haas; Xin-Ran Zhu; Hermann Lübbert; Günter Gisselmann; Hanns Hatt
Journal:  J Biol Chem       Date:  2010-05-28       Impact factor: 5.157

4.  Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization.

Authors:  S A Heldt; K J Ressler
Journal:  Neuroscience       Date:  2007-09-12       Impact factor: 3.590

5.  Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice.

Authors:  Long Cheng; Xiaoying Wang; Xueni Ma; Huimei Xu; Yifan Yang; Dekui Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.